Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
1.73 EUR | +1.76% | -0.92% | -34.96% |
Apr. 08 | Advicenne S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 25 | Advicenne: ODD designation in cystinuria | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-34.96% | 22.31M | |
-2.86% | 87.31B | |
+3.95% | 40.86B | |
-21.94% | 29.36B | |
+56.08% | 24.49B | |
-5.41% | 17.31B | |
-44.23% | 11.26B | |
-17.60% | 11.62B | |
-13.96% | 11.31B | |
+6.14% | 8.31B |
- Stock Market
- Equities
- ALDVI Stock
- News Advicenne
- Advicenne : Secures UK Approval for Rare Kidney Disease Drug